ストックスクリーナーアプリを入手
8.21
0.24%
0.02
前日終値:
$8.19
開ける：
$8.35
24時間の取引高:
12,339
Relative Volume:
0.09
時価総額：
$48.17M
収益：
-
当期純損益:
$-17.06M
株価収益率:
-0.1161
EPS:
-70.7173
ネットキャッシュフロー:
$-14.18M
1週間 パフォーマンス:
-6.92%
1か月 パフォーマンス:
-22.17%
6か月 パフォーマンス:
-86.37%
1年 パフォーマンス:
-98.68%
1日の値動き範囲:
$7.99
$8.97
1週間の範囲:
$7.72
$9.45
52週間の値動き範囲:
$7.72
$552.00
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
名前
Cns Pharmaceuticals Inc
セクター
電話
1-800-946-9185
住所
2100 WEST LOOP SOUTH, HOUSTON
CNSP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
7.99 | 48.17M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.13 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.21 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.26 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.98 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
307.01 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-12-28 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | 開始されました | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc (CNSP) 最新ニュース
CNS Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SaySwing Setup With Technical Confirmation Explained - metal.it
Published on: 2025-07-28 14:09:47 - metal.it
Will CNS Pharmaceuticals Inc. outperform the market Free Buy Low Sell High Stock Watch - Newser
Is it the right time to buy CNS Pharmaceuticals Inc. stockHigh-yield investments - jammulinksnews.com
What makes CNS Pharmaceuticals Inc. stock price move sharply 2-Day Signal Watch with Forecast Outcome - metal.it
Why is CNS Pharmaceuticals Inc. stock attracting strong analyst attentionCapitalize on trading strategies that deliver - jammulinksnews.com
How strong is CNS Pharmaceuticals Inc. company’s balance sheetExplosive earnings growth - jammulinksnews.com
Does CNS Pharmaceuticals Inc. stock perform well during market downturnsUnprecedented market success - jammulinksnews.com
Published on: 2025-07-27 20:34:14 - jammulinksnews.com
What makes CNS Pharmaceuticals Inc. stock price move sharplyFree Stock Market Courses - metal.it
CNS Pharmaceuticals Inc. Stock Analysis and ForecastFree Market Dynamics Reports - PrintWeekIndia
What drives CNS Pharmaceuticals Inc. stock priceFree Stock Movement Tracking - Autocar Professional
What analysts say about CNS Pharmaceuticals Inc. stockFree Consultation - Autocar Professional
Is CNS Pharmaceuticals Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
Why CNS Pharmaceuticals Inc. stock attracts strong analyst attentionPrecision Entry Strategy - beatles.ru
CNS Pharmaceuticals Announces Reverse Stock Split - TipRanks
CNS Pharmaceuticals to Participate in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference - 富途牛牛
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Featured In Virtual Investor Summer Spotlight Conference - Barchart.com
CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Yahoo Finance
CNS Pharmaceuticals CEO Shares Vision at Virtual Investor Conference - citybuzz -
CNS Pharmaceuticals To Carry Out 1-for-12 Reverse Stock Split On July 22nd, 2025 - 富途牛牛
CNS Pharmaceuticals Implements 1-for-12 Reverse Stock Split to Consolidate Shares and Improve Market Position - AInvest
Published on: 2025-07-19 01:04:34 - jammulinksnews.com
CNS Pharmaceuticals (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22 - Barchart.com
CNS Pharmaceuticals announces 1-for-12 reverse stock split By Investing.com - Investing.com Nigeria
CNS Pharmaceuticals announces 1-for-12 reverse stock split - Investing.com
Brain Cancer Drug Developer CNS Pharmaceuticals Announces 1:12 Reverse Split to Maintain Nasdaq Listing - Stock Titan
How CNS Pharmaceuticals Inc. stock performs during market volatility3x Growth Potential - Newser
CNS Pharmaceuticals Posts Investor Presentation on Brain Cancer - TipRanks
CNSP SEC FilingsCNS Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan
Cns Pharmaceuticals Inc (CNSP) 財務データ
収益
当期純利益
現金流量
EPS
9.66%
1.60%
大文字化:
|
ボリューム (24 時間):